Noveski P, Plaseski T, Dimitrovska M, Plaseska-Karanfilska D
Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, 1000 Skopje, Republic of North Macedonia.
University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre "Mother Teresa", 1000 Skopje, Republic of North Macedonia.
Balkan J Med Genet. 2023 Jul 31;26(1):51-56. doi: 10.2478/bjmg-2023-0012. eCollection 2023 Jul.
Sexual development (SD) is a complex process with strict spatiotemporal regulation of gene expression. Despite advancements in molecular diagnostics, disorders of sexual development (DSD) have a diagnostic rate of ~50%. Androgen insensitivity syndrome (AIS) represents the most common form of 46,XY DSD, with a spectrum of defects in androgen action. Considering the importance of very strict regulation of the SD, it is reasonable to assume that the genetic cause for proportion of the DSD lies in the non-coding part of the genome that regulates proper gene functioning. Here we present a patient with partial AIS (PAIS) due to a mosaic c.-547C>T pathogenic variant in the 5'UTR of androgen receptor () gene. The same mutation was previously described as inherited, in two unrelated patients with complete AIS (CAIS). Thus, our case further confirms the previous findings that variable gene expressivity could be attributed to mosaicism. Mutations in 5'UTR could create new upstream open reading frames (uORFs) or could disrupt the existing one. A recent systematic genome-wide study identified as a member of a subset of genes where modifications of uORFs represents an important disease mechanism. Only a small number of studies are reporting non-coding mutations in the gene and our case emphasizes the importance of molecular testing of the entire locus in AIS patients. The introduction of new methods for comprehensive molecular testing in routine genetic diagnosis, accompanied with new tools for in sillico analysis could improve the genetic diagnosis of AIS, and DSD in general.
性发育(SD)是一个复杂的过程,基因表达具有严格的时空调控。尽管分子诊断技术有所进步,但性发育障碍(DSD)的诊断率约为50%。雄激素不敏感综合征(AIS)是46,XY DSD最常见的形式,在雄激素作用方面存在一系列缺陷。考虑到性发育严格调控的重要性,有理由推测部分DSD的遗传原因在于基因组的非编码部分,该部分调节基因的正常功能。在此,我们报告一名因雄激素受体(AR)基因5'UTR区存在嵌合的c.-547C>T致病变异而导致的部分性雄激素不敏感综合征(PAIS)患者。同一突变先前在两名无关的完全性雄激素不敏感综合征(CAIS)患者中被描述为遗传性突变。因此,我们的病例进一步证实了先前的发现,即可变的基因表达可能归因于嵌合现象。5'UTR区的突变可能会产生新的上游开放阅读框(uORF),或者破坏现有的uORF。最近一项全基因组系统研究将AR确定为uORF修饰代表重要疾病机制的一组基因中的成员。只有少数研究报道了AR基因的非编码突变,我们的病例强调了对AIS患者整个AR基因座进行分子检测的重要性。在常规基因诊断中引入新的综合分子检测方法,并辅以新的计算机分析工具,总体上可以改善AIS和DSD的基因诊断。